Blair William & CO Danaher Corp Transaction History

Blair William & CO

$32 Billion
Q2 2024

A detailed history of Blair William & CO transactions in Danaher Corp stock. As of the latest transaction made, Blair William & CO holds 1,777,030 shares of DHR stock, worth $494 Million. This represents 1.39% of its overall portfolio holdings.

Number of Shares

1,777,030

Previous 1,761,264 0.9%

Holding current value

$494 Million

Previous $440 Million 0.95%

% of portfolio

1.39%

Previous 1.4%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$235.51 - $267.98 $3.71 Million - $4.22 Million	15,766 Added 0.9%	1,777,030 $444 Million
Q1 2024 May 09, 2024	BUY	$224.58 - $256.19 $8.2 Million - $9.35 Million	36,503 Added 2.12%	1,761,264 $440 Million
Q4 2023 Feb 12, 2024	BUY	$185.1 - $233.13 $7.27 Million - $9.15 Million	39,257 Added 2.33%	1,724,761 $399 Million
Q3 2023 Nov 09, 2023	BUY	$233.08 - $265.59 $5.45 Million - $6.21 Million	23,382 Added 1.41%	1,685,504 $418 Million
Q2 2023 Aug 11, 2023	BUY	$224.99 - $256.14 $4.45 Million - $5.06 Million	19,761 Added 1.2%	1,662,122 $399 Million
Q1 2023 May 12, 2023	BUY	$239.75 - $277.0 $1.48 Million - $1.71 Million	6,191 Added 0.38%	1,642,361 $414 Million
Q4 2022 Feb 10, 2023	BUY	$241.42 - $282.29 $7.81 Million - $9.13 Million	32,344 Added 2.02%	1,636,170 $434 Million
Q3 2022 Nov 09, 2022	BUY	$247.06 - $1507.4 $20.3 Million - $124 Million	82,249 Added 5.41%	1,603,826 $414 Million
Q2 2022 Aug 10, 2022	SELL	$237.11 - $299.66 $6.79 Million - $8.58 Million	-28,630 Reduced 1.85%	1,521,577 $386 Million
Q1 2022 May 13, 2022	SELL	$257.27 - $315.76 $3.52 Million - $4.32 Million	-13,697 Reduced 0.88%	1,550,207 $455 Million
Q4 2021 Feb 14, 2022	SELL	$292.08 - $329.01 $2.49 Million - $2.8 Million	-8,524 Reduced 0.54%	1,563,904 $515 Million
Q3 2021 Nov 12, 2021	SELL	$272.21 - $332.43 $10.4 Million - $12.7 Million	-38,276 Reduced 2.38%	1,572,428 $479 Million
Q2 2021 Aug 12, 2021	BUY	$225.08 - $271.69 $2.56 Million - $3.09 Million	11,390 Added 0.71%	1,610,704 $432 Million
Q1 2021 May 13, 2021	SELL	$212.38 - $245.9 $903,676 - $1.05 Million	-4,255 Reduced 0.27%	1,599,314 $360 Million
Q4 2020 Feb 09, 2021	SELL	$212.5 - $245.46 $701,887 - $810,754	-3,303 Reduced 0.21%	1,603,569 $356 Million
Q3 2020 Nov 06, 2020	SELL	$177.16 - $215.33 $8.91 Million - $10.8 Million	-50,310 Reduced 3.04%	1,606,872 $346 Million
Q2 2020 Aug 12, 2020	BUY	$128.7 - $176.83 $392,921 - $539,861	3,053 Added 0.18%	1,657,182 $293 Million
Q1 2020 May 11, 2020	SELL	$121.39 - $169.05 $16.8 Million - $23.5 Million	-138,785 Reduced 7.74%	1,654,129 $229 Million
Q4 2019 Feb 13, 2020	BUY	$133.47 - $153.48 $781,600 - $898,778	5,856 Added 0.33%	1,792,914 $275 Million
Q3 2019 Nov 12, 2019	SELL	$135.4 - $146.47 $3.03 Million - $3.28 Million	-22,372 Reduced 1.24%	1,787,058 $258 Million
Q2 2019 Aug 13, 2019	BUY	$124.88 - $143.73 $7.68 Million - $8.84 Million	61,480 Added 3.52%	1,809,430 $259 Million
Q1 2019 May 14, 2019	BUY	$97.62 - $132.29 $8.96 Million - $12.1 Million	91,804 Added 5.54%	1,747,950 $231 Million
Q4 2018 Feb 14, 2019	BUY	$94.85 - $109.54 $1.89 Million - $2.18 Million	19,908 Added 1.22%	1,656,146 $171 Million
Q3 2018 Nov 13, 2018	BUY	$98.13 - $108.9 $1.01 Million - $1.12 Million	10,276 Added 0.63%	1,636,238 $178 Million
Q2 2018 Aug 13, 2018	BUY	$96.1 - $103.24 $1.65 Million - $1.77 Million	17,166 Added 1.07%	1,625,962 $160 Million
Q1 2018 May 15, 2018	SELL	$92.16 - $103.8 $10.2 Million - $11.5 Million	-110,589 Reduced 6.43%	1,608,796 $158 Million
Q4 2017 Feb 14, 2018	SELL	$85.26 - $94.62 $535,518 - $594,308	-6,281 Reduced 0.36%	1,719,385 $160 Million
Q3 2017 Nov 13, 2017	BUY	$79.29 - $88.45 $137 Million - $153 Million	1,725,666	1,725,666 $148 Million

Others Institutions Holding DHR

# of Institutions

2,390

Shares Held

563M

Call Options Held

3.94M

Put Options Held

4.1M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $202B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account